RARECast

A podcast by RARECast - Thursdays

Thursdays

Categories:

512 Episodes

  1. Children’s National Launches First-of-its-Kind Rare Disease Center

    Published: 2/8/2017
  2. A Common Link in a Group of Rare Diseases Creates an Opportunity for Repurposing

    Published: 2/1/2017
  3. Sobi Works to Expand Rare Disease Indications for Its Drugs

    Published: 1/25/2017
  4. Why Rare Disease Patients Should Work Together to Address Common Concerns

    Published: 1/18/2017
  5. Solving Medical Mysteries with the Wisdom of Crowds

    Published: 1/11/2017
  6. Embracing Collaborations to Drive Development of Rare Disease Therapies

    Published: 1/4/2017
  7. Determining If a Child's Neurologic or Psychiatric Symptoms are Caused by an Infection

    Published: 12/28/2016
  8. Helping Patients with the Same Undiagnosed Genetic Condition Find Each Other

    Published: 12/21/2016
  9. An Entrepreneur Uses a Silicon Valley Approach to Tackle Rare Disease

    Published: 12/14/2016
  10. Looking for Love with a Rare Disease

    Published: 12/7/2016
  11. Why Genomics May Be in Google's DNA

    Published: 11/29/2016
  12. The Power of Small Grants to Make Big Impacts

    Published: 11/23/2016
  13. Building an International Registry for Rare Diseases

    Published: 11/16/2016
  14. Discovering the Creative Use of Outrage

    Published: 11/9/2016
  15. Diagnosing Rare Diseases with Facial Analysis

    Published: 11/2/2016
  16. Charles River Sees Opportunity in Fostering Rare Disease Collaborations

    Published: 10/27/2016
  17. Abeona Advancing Pipeline of Gene Therapies for Rare Diseases

    Published: 10/19/2016
  18. A Patient Attends "an Academic Conference for Everyone"

    Published: 10/12/2016
  19. Teen Advocate Preaches Message of Kindness

    Published: 10/6/2016
  20. A Controversial Approval for a Duchenne Drug and What's Ahead

    Published: 9/28/2016

21 / 26

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.